NDAQ definitive M&A: Cuprina (Nasdaq: CUPR) to Acquire EBITDA-Positive Seven-Clinic Singapore Healthcare GroupNasdaq, Inc.(NDAQ)披露确定性并购进展
NDAQ definitive M&A: Cuprina (Nasdaq: CUPR) to Acquire EBITDA-Positive Seven-Clinic Singapore Healthcare Group.
Nasdaq, Inc.(NDAQ)披露确定性并购进展。
For information only. Not investment advice.内容仅供参考,不构成投资建议。